Irakasleak
RAFAEL RODRIGUEZ PUERTAS
- Knowledge area
- Pharmacology
- Department
- Pharmacology
- Centre
- Faculty of Medicina and Nursing
- Electronic mail
- rafael.rodriguez@ehu.eus
The Principal Investigator of the research group, Dr. Rafael Rodríguez-Puertas, is assigned
to the Dept. of Pharmacology at the University of the Basque Country (UPV/EHU). He
returned in 1998 from the Karolinska Institute (Stockholm). He is one of the first and
few permanent Doctor Researchers at the UPV/EHU recognized by the ANEP (Spanish
Agency for Research Evaluation) as a researcher with outstanding career (I3 programm).
The study of the neurochemistry in Alzheimer's disease and other neurodegenerative
diseases is the main scientific interest, using radioligand binding techniques, molecular
biology, immunohistochemistry and behavioral tests. He is also experienced in the training of
researchers and PhD students. He focused in the study of the neurochemistry of Alzheimer's
as well as in projects aimed to develop new analytical technologies applied to neurochemistry
and pharmacology. The results have been published in more than 60 research papers (56
in PubMed), and more than a hundred of meetings communications. He has two licensed
patents to an spin-off company from the group. The main scientific contributions are on
cholinergic alterations in patients and animal models and its modulation by neuropeptides and
neurolipids. It is remarkable his contribution and pioneering to the development and application
in neuroscience of imaging mass spectrometry (IMS) technology. He is also integrated into the
research group for neurodegenerative diseases BioCruces.